Sandra Calvin is CAO & VP at Travere Therapeutics, Inc. (TVTX). They have made 10 open-market trades across 1 company since 2022, most recently 2026-09-15.
CIK 0001882909
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TVTX | 42,353 | $2.1M |
Shares reported on the most recent Form 4, priced at the 2026-09-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TVTX | SELL · 10b5-1 | 2026-09-15 | 2026-09-17 | $62.33 | $335K | -7.0% | — | — |
| TVTX | SELL · 10b5-1 | 2026-04-14 | 2026-04-16 | $41.07 | $903K | +1.5% | +6.5% | +40.9% |
| TVTX | SELL | 2026-02-03 | 2026-02-03 | $32.12 | $139K | -15.2% | -16.7% | +37.0% |
| TVTX | SELL · 10b5-1 | 2025-12-24 | 2025-12-29 | $40.00 | $296K | -10.4% | -21.6% | -28.4% |
| TVTX | SELL · 10b5-1 | 2025-12-15 | 2025-12-16 | $36.00 | $105K | +8.8% | -20.5% | -21.6% |
| TVTX | SELL · 10b5-1 | 2025-11-04 | 2025-11-06 | $36.00 | $2.4M | +8.3% | +3.2% | -4.7% |
| TVTX | SELL · 10b5-1 | 2025-02-11 | 2025-02-12 | $25.00 | $856K | -10.5% | -14.4% | -9.2% |
| TVTX | SELL | 2025-02-03 | 2025-02-04 | $20.12 | $135K | +8.8% | -10.1% | +1.7% |
| TVTX | SELL | 2025-01-22 | 2025-01-23 | $18.94 | $18K | +0.7% | +1.3% | -20.3% |
| TVTX | SELL · 10b5-1 | 2024-12-26 | 2024-12-27 | $17.22 | $517K | +5.5% | +17.4% | +18.8% |
| TVTX | SELL | 2024-11-25 | 2024-11-25 | $18.30 | $221K | +4.9% | -3.0% | +15.8% |
| TVTX | SELL | 2024-02-01 | 2024-02-02 | $8.53 | $24K | -0.8% | -1.6% | -26.0% |
| TVTX | SELL | 2024-01-23 | 2024-01-25 | $9.07 | $8K | -5.5% | -12.5% | -40.6% |
| TVTX | SELL · 10b5-1 | 2023-05-10 | 2023-05-12 | $16.49 | $9K | +6.1% | +8.4% | -0.8% |
| TVTX | SELL · 10b5-1 | 2023-02-01 | 2023-02-02 | $21.87 | $44K | -7.8% | +0.7% | -28.0% |
| TVTX | SELL · 10b5-1 | 2023-01-24 | 2023-01-26 | $21.85 | $24K | -0.2% | -0.5% | -5.6% |
| TVTX | SELL | 2022-09-13 | 2022-09-15 | $28.00 | $10K | -8.8% | -19.6% | -31.4% |
| TVTX | SELL | 2022-05-10 | 2022-05-12 | $21.72 | $19K | +1.5% | +6.1% | +29.1% |
| TVTX | SELL | 2022-01-31 | 2022-02-02 | $26.51 | $21K | +9.3% | +2.7% | +0.3% |
| TVTX | SELL | 2022-01-24 | 2022-01-26 | $24.58 | $23K | +4.5% | +0.8% | -0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.